Jeffrey Bailey

Jeffrey Allen Bailey is Director at Madison Vaccines, Inc. since 2017.
Independent Director at Aurinia Pharmaceuticals, Inc. and Director at Aberdeen Investments LLC since 2023.
Independent Trustee at abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund since 2020.
Former Chief Executive Officer & Director at BioDelivery Sciences International, Inc. from 2020 to 2022.
Former Chief Executive Officer & Director at IlluminOss Medical, Inc. from 2018 to 2020.
Former Chairman at Tekla Capital Management LLC from 2020 to 2023.
Former Chairman at Rein Therapeutics, Inc. from 2018 to 2023.
Former Executive Chairman & Chief Executive Officer at Neurovance, Inc. from 2015 to 2017.
Former President, Chief Executive Officer & Director at Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. from 2013 to 2015.
Former Director at Biodelivery Systems, Inc. from 2020 to 2022.
Former Chief Operating Officer at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
Former Chief Commercial Officer at KP Pharmaceuticals LLC from 2010 to 2011.
Former President & GM-Northwest Operating Unit at Novartis Pharmaceuticals Corp.
and President & General Manager at Novartis AG from 2008 to 2010.
Former Vice President-Sales at Johnson & Johnson from 1984 to 2004.
Former Independent Director at Landauer, Inc. and Director at ImaginAb, Inc. Former Vice President-Marketing at Mainevest LLC.
Education includes undergraduate degree from Rutgers State University of New Jersey.